JACC: CardioOncology (JACC:CO)
Journal Descriptions
JACC: CardioOncology is one of a family of specialist journals launched by the renowned Journal of the American College of Cardiology (JACC) . It serves to advance the cardiovascular care of cancer patients through the publication of rigorously executed, innovative science and dissemination of evidence-based knowledge. The journal seeks to transform the field of cardio-oncology and actively engage and educate the cardiovascular and oncology communities in pre-clinical, translational, and clinical research, as well as in best practices in cardio-oncology. Broad areas of interest include original research studies in disease mechanisms, in vitro and in vivo model systems, novel and conventional therapeutics (Phase I-IV), epidemiology, precision medicine, and primary and secondary prevention. Disease states of interest include, but are not limited to amyloidosis, cardiovascular risk factors, heart failure, and vascular disease.
JACC: CardioOncology (JACC:CO) is :-
-
International, Peer-Reviewed, Open Access, Refereed, Cardiovascular Medicine, Oncology, Cardiology, Epidemiology, Amyloidosis, Vascular disease , Online , Monthly Journal
- UGC Approved, ISSN Approved: P-ISSN E-ISSN: 2666-0873, Established: 2019,
- Provides Crossref DOI
-
Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE